Date Time
No more needles?
Engineers at the McKelvey School of Engineering at Washington University in St. Louis have developed a microneedle patch that can be applied to the skin, capture a biomarker of interest from interstitial fluid and, thanks to its unprecedented sensitivity, allow clinicians to detect its presence.(Image: Sisi Cao)
Blood draws are no fun.
They hurt. Veins can burst, or even roll – like they’re trying to avoid the needle, too.
Oftentimes, doctors use blood samples to check for biomarkers of disease: antibodies that signal a viral or bacterial infection, such as SARS-CoV-2, the virus responsible for COVID-19, or cytokines indicative of inflammation seen in conditions such as rheumatoid arthritis and sepsis.
1.Requirements
Candidate of national-level talent programs，tenured professor or associate professor of overseas well-known universities or research institutions, leading talent with internationally recognized achievements.
2.Support Policies
Research funds：will be discuss case by case.
Group support: At least 1 PhD student per year and unlimited numbers of post-doctoral fellows in support. Self-determination of hiring research assistant professors (RAPs) with competitive research funding support for RAPs.
Lab space about 150 square meters per person.
3.Remuneration
Salary: Globally competitive salary; Preferential policy of individual income tax, income tax of qualified high-level talents will be compensated by local government to a maximum of 15% (tax free).
Khalifa University researchers launch app to identify COVID-19 ‘High Risk’ category users
ABU DHABI, 17th January 2021 (WAM) - A team of researchers at Khalifa University of Science and Technology launched an app to collect data from smartphone users to identify, through machine intelligence, whether they are in the COVID-19 ‘high risk’ category.
The app named ‘CovidSense’ will target all mobile phone users. It will also help those users under quarantine to monitor their symptoms and location, while assisting them with their health control measures. The app will record metadata and self-reported health status data, along with breathing sounds, cough, heart rate, the GPS location from a smartphone, as well as details of those who the user has interacted with.
New algorithm could warn doctors in advance of cardiac arrest or blood clots in hospitalized COVID-19 patients
Credit: Getty images Jan 13, 2021
A team of Johns Hopkins University biomedical engineers and Johns Hopkins Medicine heart specialists have developed an algorithm that warns doctors several hours before hospitalized COVID-19 patients experience cardiac arrest or blood clots.
The COVID-HEART predictor can forecast cardiac arrest in COVID-19 patients with a median early warning time of 18 hours and predict blood clots three days in advance. It was developed with data from 2,178 patients treated at five hospitals in the Johns Hopkins Health System between March 1 and Sept. 27.
Written by AZoNanoJan 11 2021
The COVID-19 pandemic has been increasing the fears of new pathogens like drug-resistant bacteria or new viruses. A Korean research group has recently gained attention for designing a new technology to eliminate antibiotic-resistant bacteria by regulating the surface texture of nanomaterials.
Schematic diagram showing removal of bacteria biofilm via Mtex. Image Credit: Pohang University of Science and Technology.
A collaborative research group from Pohang University of Science and Technology (POSTECH) and UNIST has described a mixed-FeCo-oxide-based surface-textured nanostructures (MTex) as a highly effective magneto-catalytic platform in
Nano Letters, an international journal.
The team included professors In Su Lee and Amit Kumar together with Dr Nitee Kumari from POSTECH’s Department of Chemistry and Professor Yoon-Kyung Cho and Dr Sumit Kumar from UNIST’s Department of Biomedical Engineering.